Spinal cord injury drug trial halted early
Disease control
Completed
This study tested an experimental drug called NVG-291 in people with spinal cord injuries to see if it could help improve movement and strength. The trial was stopped early and included 24 adults with cervical spinal cord injuries. Participants received either the drug or a place…
Phase: PHASE1, PHASE2 • Sponsor: NervGen Pharma • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC